NCT04933617 2024-07-09
Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
University of California, Davis
OHSU Knight Cancer Institute
Washington University School of Medicine